GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care, dedicated to helping people see brilliantly, announced today the full U.S. commercial availability of Voyager ™ DSLT, the ...
Please provide your email address to receive an email when new articles are posted on . The Voyager direct selective laser trabeculoplasty device is now available in the U.S., according to a press ...
Alcon has bought up Belkin Vision and its laser device for treating glaucoma. The deal includes an upfront transfer of $81 million, including about $65 million in cash—plus the opportunity for up to ...
Looking back, glaucoma specialists like Dr. Christine Funke of Barnet Dulaney Perkins Eye Center can remember a time not long ago when treatment options for the eye condition were greatly limited.
Alcon has announced the US release of its Voyager direct selective laser trabeculoplasty (DSLT) platform, with a launch event scheduled for the American Glaucoma Society annual meeting later in ...
Dr. Jeffrey Whitman shares more about new options designed to lower eye pressure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results